Literature DB >> 34796594

United States Healthcare Burden of Pediatric Functional Gastrointestinal Pain Disorder Hospitalizations from 2002 to 2018.

John M Hollier1,2, Jason L Salemi3,4, Robert J Shulman1,2,5.   

Abstract

BACKGROUND: The healthcare burden of pediatric functional gastrointestinal pain disorders (FGIDs) is unclear. Our study aimed to characterize the burden of these hospitalizations in the United States (US).
METHODS: We utilized the US National Inpatient Sample from 2002 to 2018 to capture pediatric hospitalizations (ages 4 to 18 years old) with a primary discharge diagnosis of abdominal pain, constipation, irritable bowel syndrome, dyspepsia, abdominal migraine, cyclic vomiting syndrome, or fecal incontinence. We calculated the FGID hospitalization prevalence rate, length of stay (LOS), and inflation-adjusted costs annually and assessed for statistically significant trend changes using joinpoint analyses. KEY
RESULTS: 22.3 million pediatric hospitalizations were captured, and 1 in 64 pediatric hospitalizations were attributed to a primary FGID hospitalization. The overall FGID hospitalization prevalence rate initially remained stable but decreased significantly from 2013 to 2018. Constipation and abdominal pain hospitalization rates, respectively, increased and decreased significantly over time. Constipation hospitalizations were more prevalent for younger non-Hispanic Blacks and Hispanics. FGID hospitalization rates stratified by sex were similar. Mean LOS was 2.3 days; average LOS increased significantly from 2002 to 2013 and then stabilized. FGID hospitalization costs averaged $6,216 per admission and increased significantly for all FGIDs except dyspepsia. Endoscopic procedures were the most common interventions. CONCLUSIONS & INFERENCES: FGID hospitalization prevalence rates decreased recently, possibly due to national healthcare policy implementation. Nonetheless, constipation admissions increased. LOS was stable in recent years but associated costs-per-hospitalization were increasing over time, probably due to endoscopic procedures. More studies are needed to explain these prevalence and cost trends.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  abdominal pain; constipation; costs; irritable bowel syndrome; prevalence

Mesh:

Year:  2021        PMID: 34796594      PMCID: PMC9117572          DOI: 10.1111/nmo.14288

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.960


  48 in total

Review 1.  Childhood functional gastrointestinal disorders.

Authors:  A Rasquin-Weber; P E Hyman; S Cucchiara; D R Fleisher; J S Hyams; P J Milla; A Staiano
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review.

Authors:  Ami D Sperber; Dan Dumitrascu; Shin Fukudo; Charles Gerson; Uday C Ghoshal; Kok Ann Gwee; A Pali S Hungin; Jin-Yong Kang; Chen Minhu; Max Schmulson; Arkady Bolotin; Michael Friger; Tamar Freud; William Whitehead
Journal:  Gut       Date:  2016-01-27       Impact factor: 23.059

3.  The economic costs of chronic pain among a cohort of treatment-seeking adolescents in the United States.

Authors:  Cornelius B Groenewald; Bonnie S Essner; Davene Wright; Megan D Fesinmeyer; Tonya M Palermo
Journal:  J Pain       Date:  2014-06-19       Impact factor: 5.820

Review 4.  Chronic Abdominal Pain In Children: a Technical Report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Authors:  Carlo Di Lorenzo; Richard B Colletti; Horald P Lehmann; John T Boyle; William T Gerson; Jeffrey S Hyams; Robert H Squires; Lynn S Walker; Pamela T Kanda
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-03       Impact factor: 2.839

5.  The prevalence of recurrent abdominal pain in 11- to 16-year-old Malaysian schoolchildren.

Authors:  C Boey; S Yap; K L Goh
Journal:  J Paediatr Child Health       Date:  2000-04       Impact factor: 1.954

6.  Prevalence of Pediatric Functional Gastrointestinal Disorders Utilizing the Rome IV Criteria.

Authors:  Samantha G Robin; Catherine Keller; Russell Zwiener; Paul E Hyman; Samuel Nurko; Miguel Saps; Carlo Di Lorenzo; Robert J Shulman; Jeffrey S Hyams; Olafur Palsson; Miranda A L van Tilburg
Journal:  J Pediatr       Date:  2018-02-03       Impact factor: 4.406

7.  PEG 3350 Administration Is Not Associated with Sustained Elevation of Glycol Levels.

Authors:  Kent C Williams; Lynette K Rogers; Ivor Hill; John Barnard; Carlo Di Lorenzo
Journal:  J Pediatr       Date:  2018-02-01       Impact factor: 4.406

8.  Some interim results from a controlled trial of cost sharing in health insurance.

Authors:  J P Newhouse; W G Manning; C N Morris; L L Orr; N Duan; E B Keeler; A Leibowitz; K H Marquis; M S Marquis; C E Phelps; R H Brook
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

9.  Functional gastrointestinal disorders in children: an Italian prospective survey.

Authors:  Erasmo Miele; Domenico Simeone; Antonio Marino; Luigi Greco; Renata Auricchio; Steven J Novek; Annamaria Staiano
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

10.  Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites.

Authors:  Kelly M Hoffman; Sophie Trawalter; Jordan R Axt; M Norman Oliver
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.